191 related articles for article (PubMed ID: 34353274)
1. Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach.
Mohapatra PK; Srivastava R; Varshney KK; Babu SH
Anticancer Agents Med Chem; 2022; 22(10):1984-2001. PubMed ID: 34353274
[TBL] [Abstract][Full Text] [Related]
2. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
3. Amorphous isradipine nanosuspension by the sonoprecipitation method.
Tran TT; Tran PH; Nguyen MN; Tran KT; Pham MN; Tran PC; Vo TV
Int J Pharm; 2014 Oct; 474(1-2):146-50. PubMed ID: 25138256
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
Qiao F; Zhao Y; Mai Y; Guo J; Dong L; Zhang W; Yang J
Planta Med; 2020 May; 86(8):538-547. PubMed ID: 32294789
[TBL] [Abstract][Full Text] [Related]
6. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
7. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
8. Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3
Alhamhoom Y; Honmane SM; Hani U; Osmani RAM; Kandasamy G; Vasudevan R; Paramshetti S; R Dudhal R; K Kengar N; Charde MS
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771784
[TBL] [Abstract][Full Text] [Related]
9. Quality by design-based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity.
Alsabeelah N; Kumar V
J Food Biochem; 2022 Oct; 46(10):e14361. PubMed ID: 35929374
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
[TBL] [Abstract][Full Text] [Related]
11. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
[TBL] [Abstract][Full Text] [Related]
12. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of Eudragit RS-100 Based Itraconazole Nanosuspension for Ophthalmic Application.
Pawar P; Duduskar A; Waydande S
Curr Drug Res Rev; 2021; 13(1):36-48. PubMed ID: 32990554
[TBL] [Abstract][Full Text] [Related]
14. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B
Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
[TBL] [Abstract][Full Text] [Related]
17. Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid-base neutralization approach.
Chougule M; Sirvi A; Saini V; Kashyap M; Sangamwar AT
Drug Deliv Transl Res; 2023 Oct; 13(10):2503-2519. PubMed ID: 37024611
[TBL] [Abstract][Full Text] [Related]
18. Nanoformulation of
Hussain A; Attique F; Naqvi SAR; Ali A; Ibrahim M; Hussain H; Zafar F; Iqbal RS; Ayub MA; Assiri MA; Imran M; Ullah S
ACS Omega; 2023 Jan; 8(1):1088-1096. PubMed ID: 36643543
[TBL] [Abstract][Full Text] [Related]
19. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.
Shelar DB; Pawar SK; Vavia PR
Drug Deliv Transl Res; 2013 Oct; 3(5):384-91. PubMed ID: 25788346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
